SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Drezner MK 1999 Tumor-induced osteomalacia. In: FavusMJ (ed.) Primer on Metabolic Bone Diseases and Disorders of Mineral Metabolism, 4th ed. Lippincott-Raven, Philadelphia, PA, USA, pp. 319337.
  • 2
    Kumar R 2000 Tumor-induced osteomalacia and the regulation of phosphate homeostasis. Bone 27:333338.
  • 3
    Cai Q, Hodgson SF, Kao PC, Lennon VA, Klee GG, Zinsmiester AR, Kumar R 1994 Brief report: Inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia. N Engl J Med 330:16451649.
  • 4
    Wilkins GE, Granleese S, Hegele RG, Holden J, Anderson DW, Bondy GP 1995 Oncogenic osteomalacia: Evidence for a humoral phosphaturic factor. J Clin Endocrinol Metab 80:16281634.
  • 5
    Nelson AE, Namkung HJ, Patava J, Wilkinson MR, Chang AC, Reddel RR, Robinson BG, Mason RS 1996 Characteristics of tumor cell bioactivity in oncogenic osteomalacia. Mol Cell Endocrinol 124:1723.
  • 6
    Popovtzer MM 1981 Tumor-induced hypophosphatemic osteomalacia (TIO): Evidence for phosphaturic cyclic AMP-independent action of tumor extract. Clin Res 29:418A.
  • 7
    Weidner N, Santa CD 1987 Phosphaturic mesenchymal tumors. A polymorphous group causing osteomalacia or rickets. Cancer 59:14421454.
  • 8
    Madden SL, Wang CJ, Landes G 2000 Serial analysis of gene expression: From gene discovery to target identification. Drug Discov Today 5:415425.
  • 9
    Velculescu VE, Zhang L, Vogelstein B, Kinzler KW 1995 Serial analysis of gene expression. Science 270:484487.
  • 10
    Hibi K, Liu Q, Beaudry GA, Madden SL, Westra WH, Wehage SL, Yang SC, Heitmiller RF, Bertelsen AH, Sidransky D, Jen J 1998 Serial analysis of gene expression in non-small cell lung cancer. Cancer Res 58:56905694.
  • 11
    Ringel MD, Ladenson PW, Levine MA 1998 Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood. J Clin Endocrinol Metab 83:44354442.
  • 12
    Franzen A, Heinegard D 1985 Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochem J 232:715724.
  • 13
    MacDougall M, Gu TT, Luan X, Simmons D, Chen J 1998 Identification of a novel isoform of mouse dentin matrix protein 1: Spatial expression in mineralized tissues. J Bone Miner Res 13:422431.
  • 14
    Miyamoto S, Katz BZ, Lafrenie RM, Yamada KM 1998 Fibronectin and integrins in cell adhesion, signaling, and morphogenesis. Ann NY Acad Sci 857:119129.
  • 15
    Petersen DN, Tkalcevic GT, Mansolf AL, Rivera-Gonzalez R, Brown TA 2000 Identification of osteoblast/osteocyte factor 45 (OF45), a bone-specific cDNA encoding an RGD-containing protein that is highly expressed in osteoblasts and osteocytes. J Biol Chem 275:3617236180.
  • 16
    Kavanaugh MP, Miller DG, Zhang W, Law W, Kozak SL, Kabat D, Miller AD 1994 Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci USA 91:70717075.
  • 17
    Ho AM, Johnson MD, Kingsley DM 2000 Role of the mouse ank gene in control of tissue calcification and arthritis. Science 289:265270.
  • 18
    Sneath RJ, Mangham 2000 CD44 isoform expression in synovial sarcoma correlates with epitheliogenesis but not prognosis Histopathology 37:166174.
  • 19
    Uede T, Katagiri Y, Iizuka J, Murakami M 1997 Osteopontin, a coordinator of host defense system: A cytokine or an extracellular adhesive protein? Microbiol Immunol 41:641648.
  • 20
    Habets GG, Scholtes EH, Zuydgeest D, van der Kammen RA, Stam JC, Berns A, Collard JG 1994 Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell 77:537549.
  • 21
    Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T 2001 Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98:65006505.
  • 22
    Rowe PS, de Zoysa PA, Dong R, Wang HR, White KE, Econs MJ, Oudet CL 2000 MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia Genomics 67:5468.
  • 23
    Argiro L, Desbarats M, Glorieux FH, Ecarot B 2001 MEPE, the gene encoding a tumor-secreted protein in oncogenic hypophosphatemic osteomalacia, is expressed in bone. Genomics 74:342351.
  • 24
    Palmer G, Zhao J, Bonjour J, Hofstetter W, Caverzasio J 1999 In vivo expression of transcripts encoding the Glvr-1 phosphate transporter/retrovirus receptor during bone development. Bone 24:17.
  • 25
    Palmer G, Guicheux J, Bonjour JP, Caverzasio J 2000 Transforming growth factor-beta stimulates inorganic phosphate transport and expression of the type III phosphate transporter Glvr-1 in chondrogenic ATDC5 cells. Endocrinology 141:22362243.
  • 26
    Hu SI, Carozza M, Klein M, Nantermet P, Luk D, Crowl RM 1998 Human HtrA, an evolutionarily conserved serine protease identified as a differentially expressed gene product in osteoarthritic cartilage. J Biol Chem 273:3440634412.
  • 27
    Quarles LD, Drezner MK 2001 Pathophysiology of X-linked hypophosphatemia, tumor-induced osteomalacia, and autosomal dominant hypophosphatemia: a perPHEXing problem J Clin Endocrinol Metab 86:494496.
  • 28
    Econs MJ, McEnery PT 1997 Autosomal dominant hypophosphatemic rickets/osteomalacia: Clinical characterization of a novel renal phosphate-wasting disorder. J Clin Endocrinol Metab 82:674681.
  • 29
    The HYP Consortium 1995 A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet 11:130136.
  • 30
    The ADHR Consortium 2000 Autosomal dominant hypophosphatemic rickets is associated with mutations in FGF23. Nat Genet 26:345348.
  • 31
    White KE, Jonsson KB, Carn G, Hampson G, Spector TD, Mannstadt M, Lorenz-Depiereux B, Miyauchi A, Yang IM, Ljunggren O, Meitinger T, Strom TM, Juppner H, Econs MJ 2001 The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting. J Clin Endocrinol Metab 86:497500.
  • 32
    Bowe AE, Finnegan R, Jan de Beur SM, Cho J, Levine MA, Kumar R, Schiavi SC 2001 FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate. Biochem Biophys Res Commun 284:977981.
  • 33
    Vassiliadis J, Jan de Beur SM, Bowe AE, Finnegan R, Levine MA, Kumar R, Schiavi SC 2001 Frizzled related protein 4 expression is elevated in tumors associated with oncogenic osteomalacia and inhibits phosphate transport in vitro. J Bone Miner Res 16:S1;S14.